Market Overview:
The global antithrombotic treatment market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of cardiovascular diseases, increasing geriatric population, and technological advancements in the field of antithrombotic drugs. The global antithrombotic treatment market is segmented by type into NOACs, heparin, warfarin, and others. The NOACs segment is expected to grow at the highest CAGR during the forecast period owing to its advantages over other types of drugs such as ease of use and fewer side effects. The global antithrombotic treatment market is also segmented by application into hospital pharmacies, retail pharmacies, and others. The hospital pharmacies segment accounted for the largest share in 2017 owing to increased use of these drugs for prophylaxis and treatment purposes in hospitals.
Product Definition:
Antithrombotic drugs are a class of medications that help to prevent blood clots from forming. They are used to prevent and treat conditions such as deep vein thrombosis, pulmonary embolism, and stroke.
NOACs:
Antithrombotic treatment market is expected to grow at a lucrative rate during the forecast period. The major factor that propels this growth includes increasing incidences of life-threatening bleeding disorders such as hemophilia and Von Willebrand disease (VWD). According to data published by the National Hemophilia Foundation, around 30,000 babies are born with hemophilia every year in U.S alone.
Heparin:
Heparin is a type of anticoagulant drug used to prevent blood clots. It works by reducing the ability of thrombus (clot) to dissolve and spread out in the blood. Heparin can be given intravenously, orally or by injection into a vein.
Application Insights:
The other application segment held the largest share of over 50.0% in 2017. The major use of antithrombotic drugs is in the treatment of acute coronary syndrome, which includes ST-segment elevation myocardial infarction (STEMI) and non-ST-segment elevation myocardial infarction (NSTEMI). According to a study published by NCBI, it was estimated that around 603,000 patients were suffering from heart attack across the globe in 2015 and around strokes as well as cardiac arrest cases were also reported during that same year. Thus, increasing incidence rates for cardiovascular diseases are expected to fuel demand for new innovative products such as antiplatelet drugs and anticoagulants during the forecast period.
Regional Analysis:
North America dominated the global antithrombotic treatment market in 2017. The presence of favorable government initiatives, increased healthcare expenditure, and high incidence of CVDs & stroke are some major factors responsible for its large share. In addition, the availability of highly developed healthcare infrastructure and advanced medical products is expected to drive this regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income leading to an increase in demand for various medical treatments such as anticoagulants & antiplatelet drugs among others which are associated with a higher price tag in this region as compared to other regions. Moreover, increasing prevalence of CVDs & diabetes also drives its demand since it increases thrombus formation thus promoting growth during the forecast period.
Growth Factors:
- Increasing incidence of thrombotic disorders: The global antithrombotic treatment market is expected to grow at a CAGR of 5.5% during the forecast period due to the increasing incidence of thrombotic disorders such as myocardial infarction, stroke, and venous thromboembolism.
- Growing geriatric population: The geriatric population is more susceptible to developing thrombotic disorders, which is expected to drive the demand for antithrombotics in the coming years.
- Technological advancements in antithrombotics: The development of novel oral anticoagulants (NOACs) and other advanced therapies has revolutionized the treatment landscape for patients with thromboembolic diseases and is anticipated to boost growth prospects for this market over the forecast period.
- Rising awareness about prevention and early diagnosis of thombotic disorders: There has been an increase in awareness among people about prevention and early diagnosis of various types of thombotic disorders, which is likely to fuel demand for effective treatments such as antithormbotics in the coming years.. 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Antithrombotic Treatment Market Research Report
By Type
NOACs, Heparin, Warfarin, Others
By Application
Hospital, Drugs Stores, Other
By Companies
Bristol-Myers Squibb, Bayer, Pfizer, Johnson & Johnson, Sanofi, Boehringer Ingelheim, Daiichi Sankyo
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
154
Number of Tables & Figures
108
Customization Available
Yes, the report can be customized as per your need.
Global Antithrombotic Treatment Market Report Segments:
The global Antithrombotic Treatment market is segmented on the basis of:
Types
NOACs, Heparin, Warfarin, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drugs Stores, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bristol-Myers Squibb
- Bayer
- Pfizer
- Johnson & Johnson
- Sanofi
- Boehringer Ingelheim
- Daiichi Sankyo
Highlights of The Antithrombotic Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- NOACs
- Heparin
- Warfarin
- Others
- By Application:
- Hospital
- Drugs Stores
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Antithrombotic Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Antithrombotic treatment is a type of medical care that helps to prevent blood clots from forming. This can help to reduce the risk of serious complications, such as stroke or heart attack. Antithrombotic medications can be used alone or in combination with other treatments, such as surgery.
Some of the key players operating in the antithrombotic treatment market are Bristol-Myers Squibb, Bayer, Pfizer, Johnson & Johnson, Sanofi, Boehringer Ingelheim, Daiichi Sankyo.
The antithrombotic treatment market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Antithrombotic Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Antithrombotic Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Antithrombotic Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Antithrombotic Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Antithrombotic Treatment Market Size & Forecast, 2018-2028
4.5.1 Antithrombotic Treatment Market Size and Y-o-Y Growth
4.5.2 Antithrombotic Treatment Market Absolute $ Opportunity
Chapter 5 Global Antithrombotic Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Antithrombotic Treatment Market Size Forecast by Type
5.2.1 NOACs
5.2.2 Heparin
5.2.3 Warfarin
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Antithrombotic Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Antithrombotic Treatment Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drugs Stores
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Antithrombotic Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Antithrombotic Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Antithrombotic Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Antithrombotic Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Antithrombotic Treatment Market Size Forecast by Type
9.6.1 NOACs
9.6.2 Heparin
9.6.3 Warfarin
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Antithrombotic Treatment Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drugs Stores
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Antithrombotic Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Antithrombotic Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Antithrombotic Treatment Market Size Forecast by Type
10.6.1 NOACs
10.6.2 Heparin
10.6.3 Warfarin
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Antithrombotic Treatment Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drugs Stores
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Antithrombotic Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Antithrombotic Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Antithrombotic Treatment Market Size Forecast by Type
11.6.1 NOACs
11.6.2 Heparin
11.6.3 Warfarin
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Antithrombotic Treatment Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drugs Stores
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Antithrombotic Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Antithrombotic Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Antithrombotic Treatment Market Size Forecast by Type
12.6.1 NOACs
12.6.2 Heparin
12.6.3 Warfarin
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Antithrombotic Treatment Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drugs Stores
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Antithrombotic Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Antithrombotic Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Antithrombotic Treatment Market Size Forecast by Type
13.6.1 NOACs
13.6.2 Heparin
13.6.3 Warfarin
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Antithrombotic Treatment Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drugs Stores
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Antithrombotic Treatment Market: Competitive Dashboard
14.2 Global Antithrombotic Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bristol-Myers Squibb
14.3.2 Bayer
14.3.3 Pfizer
14.3.4 Johnson & Johnson
14.3.5 Sanofi
14.3.6 Boehringer Ingelheim
14.3.7 Daiichi Sankyo
